Filing Details

Accession Number:
0001179110-18-002676
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-23 11:46:22
Reporting Period:
2018-02-21
Accepted Time:
2018-02-23 11:46:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1701531 Thomas Ryll C/O Immunogen, Inc.
830 Winter Street
Waltham MA 02451
Vp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-21 11,876 $10.88 96,224 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Weighted average price of shares sold.
  2. The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.